Low-risk prostate cancer well managed with active surveillance

November 1, 2009
Leonard S. Marks, MD

,
Scott B. Shappell, MD, PhD

Drs. Scott B. Shappell and Leonard S. Marks discuss clinical use of urine PCA3 mRNA testing for prostate cancer.